Contact Us   |   Print Page   |   Sign In   |   Join
Share |





Tuesday, October 10, 2017

8:00 a.m.

Continental Breakfast

On-Site Registration

8:30 a.m.

Program Starts

Welcome | Opening Remarks

8:45 a.m.

Drug Discovery Session 1


Jetze Tepe, PhD, Associate Professor of Chemistry, Department of Chemistry, Michigan State University: Modulating proteasome function for cancer and neurodegenerative therapeutics

Kang Chen, PhD, Assistant Professor of Obstetrics and Gynecology, Immunology and Microbiology, Oncology, Wayne State University:

Progesterone-induced blocking factor 1 (PIBF1) for the prevention and treatment of preterm birth

David Sherman, PhD, Hans W. Vahlteich Professor of Medicinal Chemistry, University of Michigan:

Strategy for using natural products in drug discovery



10:15 a.m.

Drug Discovery Session 2


Zhiqiang Cao, Associate Professor, Chemical Engineering, Wayne State University:

Cell encapsulation technologies


Matthias Kretzler, MD, Warner-Lambert/Parke-Davis Professor of Internal Medicine/Nephrology and Computational Medicine and Bioinformatics, University of Michigan:

Precision medicine for chronic kidney disease
Simon Petersen-Jones, DVetMed, PhD, DVOphthal, DipECVO, Donald R Myers and William E Dunlap Endowed Chair in Canine Health; Professor, Comparative Ophthalmology, College of Veterinary Medicine, Michigan State University:

Veterinary clinical trials of gene therapy of eye diseases as a path to human therapeutics

11:30 a.m.

Keynote Speaker


John S. Lazo, PhD, Harrison Distinguished Professor, Departments of Pharmacology & Chemistry, 

Associate Director for Basic Science, UVA Cancer Center:

The Challenges and Opportunities for Academic Drug Discovery Consortia


12:30 p.m.


Lunch Break | Posters | Exhibitors


2:00 p.m.

Julia Owens, PhD, President & CEO, Millendo Therapeutics

A Biotech Case Study on the Ups and Downs of Drug Development: Millendo Therapeutics

2:45 p.m.

Panel Discussion: Overview of Drug Discovery Programs/Resources/Gaps


Moderator: Britany Affolter-Caine, PhD, Interim Executive Director, University Research Corridor (URC)


Roger Cone, PhD, Executive Director, Life Sciences Institute, University of Michigan


Douglas Gage, PhD, Assistant Vice President for Research and Graduate Studies, Michigan State University


Stephen Lanier, PhD, Vice President for Research, Wayne State University

4:00 p.m.

Panel Discussion: Pros & Cons of Creating Tri-MI University Drug Discovery Alliance


Moderator: Stephen Rapundalo, PhD, President and CEO, MichBio


Vince Groppi, PhD, Director, Center for the Discovery of New Medicines, University of Michigan


Richard Neubig, PhD, Chairman, Department of Pharmacology & Toxicology, Michigan State University


Terrence Monks, PhD, Professor, Department of Pharmaceutical Sciences, Wayne State University

4:45 p.m. Closing Remarks

5:00 p.m.

- 6:30 p.m.

Networking Reception









Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal